scholarly journals Erratum: Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches

Leukemia ◽  
2017 ◽  
Vol 32 (2) ◽  
pp. 574-574
Author(s):  
S Pearson ◽  
A J K Williamson ◽  
R Blance ◽  
T C P Somervaille ◽  
S Taylor ◽  
...  
Biomolecules ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1164
Author(s):  
Siying Song ◽  
Linlin Guo ◽  
Di Wu ◽  
Jingfei Shi ◽  
Yunxia Duan ◽  
...  

Background: Animal and clinical studies have shown that remote ischemic conditioning (RIC) has protective effects for cerebral vascular diseases, with induced humoral factor changes in the peripheral blood. However, many findings are heterogeneous, perhaps due to differences in the RIC intervention schemes, enrolled populations, and sample times. This study aimed to examine the RIC-induced changes in the plasma proteome using rhesus monkey models of strokes. Methods: Two adult rhesus monkeys with autologous blood clot-induced middle cerebral artery (MCA) occlusion underwent RIC interventions twice a week for five consecutive weeks. Each RIC treatment included five cycles of five minutes of ischemia alternating with five minutes of reperfusion of the forearm. The blood samples were taken from the median cubital vein of the monkeys at baseline and immediately after each week’s RIC stimulus. The plasma samples were isolated for a proteomic analysis using mass spectrometry (MS). Results: Several proteins related to lipid metabolism (Apolipoprotein A-II and Apolipoprotein C-II), coagulation (Fibrinogen alpha chain and serpin), immunoinflammatory responses (complement C3 and C1), and endovascular hemostasis (basement membrane-specific heparan sulfate proteoglycan) were significantly modulated after the RIC intervention. Many of these induced changes, such as in the lipid metabolism regulation and anticoagulation responses, starting as early as two weeks following the RIC intervention. The complementary activation and protection of the endovascular cells occurred more than three weeks postintervention. Conclusions: Multiple protective effects were induced by RIC and involved lipid metabolism regulation (anti-atherogenesis), anticoagulation (antithrombosis), complement activation, and endovascular homeostasis (anti-inflammation). In conclusion, this study indicates that RIC results in significant modulations of the plasma proteome. It also provides ideas for future research and screening targets.


2008 ◽  
Vol 169 (4) ◽  
pp. 417-425 ◽  
Author(s):  
Xiaoping Ao ◽  
David M. Lubman ◽  
Mary A. Davis ◽  
Xianying Xing ◽  
Feng-Ming Kong ◽  
...  

2010 ◽  
Vol 78 (2) ◽  
pp. 547-554 ◽  
Author(s):  
Vasily A. Yakovlev ◽  
Christopher S. Rabender ◽  
Heidi Sankala ◽  
Ben Gauter-Fleckenstein ◽  
Katharina Fleckenstein ◽  
...  

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
David Michalovich ◽  
Noelia Rodriguez-Perez ◽  
Sylwia Smolinska ◽  
Michal Pirozynski ◽  
David Mayhew ◽  
...  

AbstractIn order to improve targeted therapeutic approaches for asthma patients, insights into the molecular mechanisms that differentially contribute to disease phenotypes, such as obese asthmatics or severe asthmatics, are required. Here we report immunological and microbiome alterations in obese asthmatics (n = 50, mean age = 45), non-obese asthmatics (n = 53, mean age = 40), obese non-asthmatics (n = 51, mean age = 44) and their healthy counterparts (n = 48, mean age = 39). Obesity is associated with elevated proinflammatory signatures, which are enhanced in the presence of asthma. Similarly, obesity or asthma induced changes in the composition of the microbiota, while an additive effect is observed in obese asthma patients. Asthma disease severity is negatively correlated with fecal Akkermansia muciniphila levels. Administration of A. muciniphila to murine models significantly reduces airway hyper-reactivity and airway inflammation. Changes in immunological processes and microbiota composition are accentuated in obese asthma patients due to the additive effects of both disease states, while A. muciniphila may play a non-redundant role in patients with a severe asthma phenotype.


2006 ◽  
Vol 5 (10) ◽  
pp. 2656-2665 ◽  
Author(s):  
G. E. Kisby ◽  
M. Standley ◽  
T. Park ◽  
A. Olivas ◽  
S. Fei ◽  
...  

PROTEOMICS ◽  
2010 ◽  
Vol 10 (1) ◽  
pp. 99-114 ◽  
Author(s):  
Elke Hammer ◽  
Sandra Bien ◽  
Manuela Gesell Salazar ◽  
Leif Steil ◽  
Christian Scharf ◽  
...  

2006 ◽  
Vol 5 (1) ◽  
pp. 54-63 ◽  
Author(s):  
Minerva A. Hughes ◽  
Jeffrey C. Silva ◽  
Scott J. Geromanos ◽  
Craig A. Townsend

Sign in / Sign up

Export Citation Format

Share Document